Background. Although chronic peritoneal dialysis (CPD) is considered the replacement therapy of choice for infants with end-stage renal failure, many questions persist about treatment risks and outcomes. Methods. We present data on 84 infants who started CPD at <1 year of age; these patients represent 12% of the total population of the Italian Registry of Paediatric Chronic Dialysis. We analysed patient records from all children consecutively treated with CPD between 1995 and 2007 in Italy. Growth data analysis was performed only in infants with complete auxological parameters at 0, 6 and 12 months of follow-up. Results. Median age at the start of CPD was 6.9 months, weight was 6.1 kg and length 63.6 cm. In one-half of the study population diagnosis leading to renal failure was congenital nephrouropathy. Twenty-eight per cent of the children had at least one pre-existing comorbidity. The mean height standard deviation score was À1.65 at the start of CPD, À1.82 after 12 months and À1.53 after 24 months. Catch-up growth was documented in 50% of patients during dialysis. A positive correlation was observed between longitudinal growth and both exchange volume (R 2 ¼ 0.36) and dialysis session length (R 2 ¼ 0.35), while a negative association was found with the number of peritonitis cases (P ¼ 0.003). Peritonitis incidence was 1:20.7 episode:CPD-months (1:28.3 in the older children from the same registry) and was significantly higher in children with oligoanuria (1:15.5 episode:CPD-months) compared to infants with residual renal function (1:37.4 episode:CPD-months). Catheter survival rate was 70% at 12 months and 51% at 24 months. Catheter-related complications were similar in infants and older children (1:20.5 versus 1:19.8 episode: CPD-months), while clinical complications were more frequent in children under 1 year of age (1:18.3 versus 1:25.2 episode:CPD-months; P < 0.05). During the follow-up period, 33 patients were transplanted (39.3%), 18 were shifted to haemodialysis (21.4%) and 8 died (9.5%). The mortality rate was 4-fold greater than in older children (2.3%). Conclusions. Our data confirm that infants on CPD represent a high-risk group; however, our experience demonstrated that growth was acceptable and a large portion was successfully transplanted. Increased efforts should be aimed at optimizing dialysis efficiency and preventing peritonitis. The higher mortality rate in infants was largely caused by comorbidities.
Introduction
Although chronic peritoneal dialysis (CPD) is the preferred dialysis modality for most infants with end-stage renal disease (ESRD), many questions persist about risk factors and CPD outcomes in this group of patients. Mortality, infections and growth failure are of greater concern in infants on CPD than in children or adults on this modality [1] . For these reasons, only~50% of paediatric nephrologists preferred initiation of renal replacement therapy (RRT) for ESRD children having <1 year of age at the end of the 1990's [2] . RRT in infants was considered unjustified because of technical problems and ethical dilemmas involving patient outcomes. Since then, this attitude has been modified by reports demonstrating favourable results in growth, development and renal transplantation in infants on CPD given careful medical and nutritional management [3, 4] . However, the literature in this area is still limited and comes primarily from single-centre experiences [5] [6] [7] .
In this study, we retrospectively reviewed data on clinical characteristics, treatment evolution, morbidity and mortality and growth by analysing files from patients starting CPD at <1 year of age, collected over a 13-year period by the Italian Registry of Paediatric Chronic Dialysis.
Materials and methods
We analysed patient records of all children consecutively treated with CPD between 1995 and 2007 in Italy. We then assessed the data of all 84 infants starting CPD under 1 year of age, which represented 22% of the incident CPD patients (381 cases) and 12% of the whole population of the Italian Registry of Paediatric Chronic Dialysis (681 cases). Twenty babies started dialysis between 0 and 3 months, 17 between 4 and 6 months and 47 between 7 and 12 months of age. During the same time period (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) , there were no ESRD patients in the registry under 1 year of age reported as being treated with haemodialysis. The infants in our study had been treated in 11 of the 18 centres participating in the registry for a total of 1761 months of CPD (median duration 19.3 months; range 1-55).
Height and body weight were recorded at baseline (60 cases), at 6 and 12 months (47) and at 2 years of dialysis follow-up (30) . Both these parameters were normalized as standard deviation score (SDS) for chronological age using the 'LMS method' described by Cole [8] and according to CDC growth charts [9] . SDS per year (dSDS) was calculated in 47 infants by comparing the length SDS value at 12 months with the value at baseline, and a positive result was regarded as catch-up growth. Statistical analysis of comparisons between the two groups of infants with different growth velocities was performed using Student's t-tests for parametric data and Mann-Whitney U-tests for non-parametric data. Statistical significance was defined as P <0.05.
For analysis of complications, we assessed the incidence and characteristics of peritonitis, peritoneal catheter complications [exit-site infection (ESI), obstruction, leakage, cuff extrusion] and clinical complications (over-or dehydration, malnutrition, hernias). An alteration in hydration status was considered clinically significant only if it was a cause of hospitalization. Peritonitis was defined according to the International Society for Peritoneal Dialysis recommendations [10] as the presence of at least two of the following criteria: signs and symptoms of peritoneal irritation; peritoneal cellularity in a cloudy effluent >100 cells/mm 3 and positive culture. Catheter ESI was defined as the presence of a purulent discharge from the sinus tract or marked pericatheter swelling, redness and/or tenderness, with or without a pathogenic organism cultured from the exit site. Rates of complications in infants receiving CPD were compared with those calculated in older children from the same registry. Statistical analysis for comparison of complications rates between the two age groups was performed using non-parametric tests (Mann-Whitney).
Results

Clinical characteristics
Median age at the start of CPD was 6.9 months (range 0.01-10.8), body weight was 6.1 kg (range 1.9-11.7) and length 63.6 cm (range 41-85). Diagnoses leading to renal failure were congenital anomalies of kidney and urinary tract (CAKUT, 49%), congenital nephrotic syndrome (14%), neonatal cortical necrosis (7%), autosomal recessive polycystic kidney disease (ARPKD, 7%), primary hyperoxaluria type 1 (6%), haemolytic-uraemic syndrome (6%), angiotensin-converting enzyme inhibitor congenital nephropathy (1%) and undiagnosed nephropathy (10%).
Twenty-eight per cent of the children had at least one pre-existing medical comorbidity, ranging from prematurity (gestational age <37 weeks; n ¼ 2), delay in psychomotor development (n ¼ 4), liver disease with or without cholestasis (n ¼ 4), visual impairment (n ¼ 4), hypoxicischaemic encephalopathy (n ¼ 2), congenital heart disease (n ¼ 2), polymalformative syndrome (n ¼ 2), hypothyroidism (n ¼ 2), Wilms' tumour (n ¼ 2), pulmonary hypoplasia (n ¼ 2) and bronchopulmonary dysplasia (n ¼ 1).
Treatment modalities and prescription
Data on 77 peritoneal catheters positioned at the beginning of dialysis were available for description (Table 1) ; there was no catheter information from seven patients in the registry database. All catheters were surgically implanted at treatment onset and omentectomy was performed in 97% of cases. Seventy-three catheters were Tenckhoff type (95%) and only four 'Missouri' type (5%). The entry site was mostly paramedian (82%) and exit site was downward oriented in the majority of cases (73%). During the three observation periods (1995-99, 2000-03, 2004-07) , the proportion of curled and double-cuff catheters progressively increased.
Continuous ambulatory peritoneal dialysis (PD) was applied as initial treatment in 30% of infants when the fill volume was <100 mL. After 12 months of follow-up, all children were on automated cycler PD (APD) regimens, either without daytime dwell (nightly intermittent PD, NIPD) (63%) or with daytime dwell (continuous cycling PD, CCPD) (37%). Eighteen per cent of infants, all with residual urine output, started APD in tidal modality and the percentage increased to 30% after 2 years of treatment. During the entire follow-up period, the proportion of children on CCPD was maintained between 30 and 40%. Characteristics of CPD prescription and delivery are shown in Table 2 . A progressive increase in the mean fill volume occurred over the time course of dialysis, while median treatment duration remained stable at around 10-11 h. At the beginning of CPD treatment, a bicarbonate-based PD solution was employed in 31% of patients, but this figure decreased to 10 and 5% at 12 and 24 months of follow-up, respectively. Eighty-four per cent of infants were dialysed with low-glucose PD solutions and this proportion remained mostly constant at 12 months (84%) and 24 months (77%) of treatment. A very low volume of icodextrin solution (200 mL/m 2 ) was used in two infants on APD for the long day dwell. The median duration of hospitalization for APD family training was 25 days (range 10-53) in babies <6 months of age and 14.5 days (range 6-30) in older infants. There was no significant relationship between the duration of training and incidence of peritonitis.
Growth analysis
During the entire CPD period, body weight deficits were more pronounced than length impairments. In the entire population, growth failure was observed during the first 6 months of treatment; however, both auxological parameters gradually recovered after this period to near normal SDS values ( Figure 1 ). Catch-up growth was documented in 49% of patients during dialysis (23/47): the mean dSDS was 11.2 AE 1.2 in this group of children and was -1.0 AE 0.9 in those (24 cases) without catch-up growth (P < 0.001). Infants who did show catch-up growth exhibited a more severe length deficit at the start of CPD (Table 3) . Primary renal disease distribution and several laboratory parameters were similar in the two groups of infants with different growth velocities. Moreover, infants with catch-up growth were not significantly different from those without catch-up growth in terms of mean daily diuresis, incidence of comorbidities and number of patients given recombinant growth hormone (rGH) therapy (Table 4) . On the other hand, infants with a negative dSDS experienced a greater number of peritonitis episodes during CPD treatment (P ¼ 0.003); peritonitis rates were 1 episode:6.5 CPD-months for infants without catch-up growth, which was significantly greater than in those with a positive dSDS (1:48 episode:CPD-months). Analysis of dialysis parameters revealed that the two groups had similar dialysis prescriptions at the start of CPD; however, infants with catch-up growth received significantly greater exchange volumes and longer dialysis sessions (P ¼ 0.045) after 12 months of treatment. Linear relationships between dialysis parameters and longitudinal growth were evaluated using the Pearson's correlation test; a mild linear relationship was found both for fill volume (R 2 ¼ 0.36) and treatment duration (R 2 ¼ 0.35) (Figure 2 ).
Peritonitis and other complications
Eighty-six cases of peritonitis were reported in 42 patients (50%), with an overall incidence of 1 episode every 20.7 CPD-months (1:28.3 in the older children of the registry; P < 0.05). Thirteen per cent of infants were affected by three or more peritonitis episodes, while 74% showed one or no episodes. Peritoneal catheters were single cuffed in 44% of infants who developed peritonitis and in 11% of children who had no peritonitis episodes (P < 0.05). Peritoneal catheter ESI and/or tunnel infections were present in 61% of peritonitis episodes. Prophylactic antibiotics at the exit site were not part of routine care. Peritonitis rates were significantly higher in infants with oligoanuria than in those with residual urine output (1:15.5 versus 1:37.4 episode:CPD-months; P < 0.05). Daily diuresis of the infants was measured by weighing diapers and oligoanuria was defined as urine output <0.5 mL/kg/h. The most commonly observed organisms were Gram-positive cocci (57%), followed by Enterobacteriaceae (16%), Pseudomonas spp. (13%) and Candida spp. (11%). In older infants, the proportion of mycotic infection was lower (6%), with Gram-positive bacteria representing the most frequent causative agents (61%). The clinical diagnosis of peritonitis was made according to the following signs and/or symptoms: abdominal pain and/or vomiting in 54/86 cases (63%), fever in 46/86 (53%), cloudy effluent in 56/86 (65%) and increases in peritoneal effluent cellularity in 74/86 (86%). Peritoneal effluent culture was positive in 67 of 86 episodes (78%). Catheter-related complications occurred at similar rates in infants and older children (1:17 versus 1:19.8 episode:CPD-months). During the most recent period (2004-07), we observed a significant reduction in catheter-related complications in infants, yielding an incidence of 1:26.1 episodes:CPD-months (Table 1) . Catheter survival was 70% after 1 year following CPD treatment in 70 children and 51% in 63 infants during a 2-year follow-up period. Forty-seven episodes of ESI and 14 episodes of tunnel infections were also reported, with an overall incidence of 1:28 episode:CPD-months. The most frequent catheter mechanical complication was obstruction (n ¼ 9), followed by catheter displacement (n ¼ 6), cuff extrusion (n ¼ 3) and leakage (n ¼ 3). Repositioning of the peritoneal catheter was performed in 9 of 61 catheter-related infections (15%), and this was necessary in all complications of mechanical origin. The hospitalization rate for overall peritoneal catheterrelated causes was 0.2 days per CPD-month. Clinical complications (over-or dehydration episodes, malnutrition, hernias) were more frequent in infants under 1 year of age (1:18.3 versus 1:25.2 episode:CPD-months; P < 0.05). Ninety-six clinical complications were recorded in our population, resulting in a median hospitalization time of 7 days (range 0-105); hospitalization rates for CPDrelated causes were 1.2 and 0.6 days per CPD-month in infants and older children, respectively, (P < 0.05).
Long-term outcomes
During the follow-up period, 33 patients (39.3%) received kidney transplant from deceased donors after a median time on dialysis of 29 months (range 2.2-55 months), at a median age of 30.1 months (range 6-55.6 months) and with a median body weight of 11 kg (range 5.5-15 kg). Eighteen children (21.4%) were shifted to haemodialysis due to ultrafiltration failure (7 cases) or peritonitis (11 cases) after a median time on CPD of 14 months (range 2-39.3 months) 
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and 20 months (range 2.4-47.1 months), respectively. Thirty per cent of infants who had more than three peritonitis episodes were shifted to haemodialysis, compared to 10% of those who remained peritonitis 'free'. During the entire observation period (1761 months of CPD), eight patients died at a median age of 12.3 months and after a median time on CPD of 11.8 months (range 0.5-36.4 months). Causes of death were septic shock (four cases), respiratory failure (two cases), cerebral venous thrombosis and pulmonary embolism (one case each). Mortality was significantly higher than in older children (9.5 versus 2.3%), with an incidence of 1:18 CPD-years. Fifty per cent of the deceased infants were affected by at least one comorbidity. Mortality rates were 2-fold higher in infants who had comorbidities (15%) than among those who had none (7%); moreover, patients with comorbidities died after a median treatment time of 9.6 months (range 0.5-13.4), whereas infants without comorbidities showed a significantly longer median CPD treatment before death (14.1 months; range 10.4-36.4; P < 0.05). Eighteen infants (21%) were maintained on long-term PD (PD duration >36 months; median 42.6 months; range 37-58.5). In this group of patients, low body weight due to growth retardation represented the main factor leading to delayed transplant. Eighty per cent of these infants failed to show catch-up growth after 12 months of CPD treatment. Most patients were affected by CAKUT (65%). They had a mean daily diuresis of 500 mL, which was larger than that of the remainder sample of infants (138 mL; P < 0.05). Moreover, infants on long-term PD exhibited lower incidences of comorbidities (17%), peritonitis (1:34 CPDmonths) and catheter-related complications (1:37 CPD-months) (P < 0.05). The incidence of clinical complications and the frequency and duration of hospitalizations were similar to those of the whole sample of infants. A high percentage of these children (80%) routinely used the nasogastric tube for nutrition during the first year of dialysis; after 36 months of CPD, enteral nutrition support by means of percutaneous gastrostomy was provided in only four patients. Infants on long-term PD received standard medication for their ESRD: the median erythropoietin dose before transplantation was 220 U/kg/week and the median calcitriol dose was 0.02 mcg/kg/day. Kidney transplants were successfully performed in 70% of these patients within 12-18 months after attainment of at least 10 kg body weight.
CPD in neonates
A subanalysis was conducted to assess complications and outcomes in 20 infants that started CPD during the first month of life ( 28 days). Published data concerning care of neonates with ESRD is scarce and our findings may help paediatric nephrologists during family discussions and during decisions whether CPD should be initiated.
Neonates were more likely to be diagnosed with CAKUT (11/20) or ARPKD (5/11). In this setting, the incidence of peritonitis was 1:10 episode:CPD-months, while it was 1:30 episode:CPD-months in the 64 infants who initiated dialysis at age >28 days (P < 0.05). Similarly, neonates on CPD exhibited a significantly greater incidence of clinical (1:15.5 versus 1:27.2 episode:CPD-months) complications, while the incidence of catheter-related complications was similar (1:16 versus 1:18 episode:CPD-months). In terms of catheter problems, neonates suffered from a greater number of mechanical complications, all requiring the need for catheter repositioning. In 45% of cases, a single-cuff catheter was implanted at the start of CPD during neonatal age. The hospitalization rate for overall CPD-related causes in neonates was 1.7 days per CPD-month.
Catch-up growth was observed in 35% of neonates, whereas a growth failure persisted in others after 1 year of dialysis treatment. Four (20%) children starting CPD at neonatal age received a deceased-donor kidney transplant after a median time of 28.5 months, six were shifted to haemodialysis (30%) and three (15%) experienced a recovery of native kidney function after a median dialysis time of 1.2 months. Four infants starting CPD at neonatal age died after a median duration treatment of 8.7 months, resulting in a high mortality rate (20%). Causes of death were respiratory failure and septic shock, and comorbidities were present in all of these children (prematurity, bronchopulmonary dysplasia, congenital heart disease and hypoxicischaemic encephalopathy).
Discussion
The clinical management of infants with ESRD is one of the greatest challenges for the paediatric nephrologist. The decision to start RRT is frequently accompanied by ethical and emotional dilemmas experienced by parents and medical staff [11] . Infants represent only 1-2% of the entire ESRD paediatric population [12] but their management creates a significant workload. Nevertheless, studies of infants on CPD are scarce, and descriptions of long-term outcomes are rare [3] [4] [5] [6] [7] .
In our 13-year experience, infants represented 22% of the paediatric population on CPD. During the same period at the centres participating in the Italian Registry, there were no babies aged <1 year that started RRT with haemodialysis. The proportion of infants in the entire patient population of the Italian Registry has almost doubled since the previous paper published from registry data [3] . They represent the second largest case series ever reported, the first being that of the NAPRTCS report [13] . However, ours is the first case series to provide this amount of information about this particular population.
In our population, the most common PD delivery system was the curled double-cuffed Tenckoff catheter (felt cuffs, 7.5 mm length), which had a straight tunnel and was downward oriented with a paramedian exit site. This PD access modality is among the most frequent combinations reported by NAPRTCS [13] , and the one-cuffed catheter with lateral exit site is the most commonly used (14.4%); it also represents the standard paediatric catheter type used in Mid Europe [14] . It is surprising that double-cuff catheters have seen increased use since body weights <5 kg have been a great concern for catheter implantation in neonates and young children. In small children, the exit-site location should be above the diaper area to minimize the risk of contamination [15] . Therefore, a presternal exit-site location may be particularly beneficial in infants [16] .
According to our results, 30% of infants started on manual intermittent PD, while automated cycler was introduced later when the exchange volume was at least 100 mL. Automated PD requires suitable parent training but makes home management of the treatment easier and reduces hospitalization times [17] . In our case series, NIPD was the APD modality of choice in 70% of infants during the entire period of follow-up. Moreover, a significant proportion of children started APD in tidal modality.
The infant peritoneum has a high intrinsic membrane permeability and achieves the most rapid and complete equilibration for urea because of a relatively large effective peritoneal surface area [18] . NIPD with short exchanges is primarily indicated for patients characterized by a hightransport peritoneal membrane, which rapidly loses the osmotic gradient for ultrafiltration and allows swift solute equilibration [19] . This type of treatment may lead to the discrepancy of normal lowrange urea combined with highrange creatinine during assessment of dialysis adequacy [20] . To correct this and to optimise phosphate and middlemolecule clearances, tidal PD is often prescribed [21] .
According to our data, the mean initial fill volume was well elevated (556 mL/m 2 ) and it increased during 2 years of treatment to finish at 70-80% of the NKF KDOQI target (1000-1200 mL/m 2 ) [22] . However, the mean fill volume after 24 months of dialysis was 100% of the upper limit as suggested for infants on CPD by Fischbach et al. [23] . In fact, the fill volume should be based more on tolerance than on an optimal dialytic exchange volume in children <2 years [24] . However, because a too small fill volume may lead to a hyperpermeable status, the bedside measurement of hydrostatic intraperitoneal pressure can be of potential assistance in prescribing adequate fill volumes [25] .
In the Italian experience, the proportion of infants treated with bicarbonate-based PD solutions was less than expected considering the better biocompatibility of bicarbonate buffered than conventional PD solutions [26] . A good adequacy of acid-base correction obtained with lactate buffers and the higher cost of PD bicarbonate solution bags have probably limited their employment in our sample of infants.
In patients at the paediatric age, dialysis should be considered as a transition period before receiving renal transplantation; in particular, dialysis treatment should have the goal of attaining adequate body weights for receiving a renal transplant. In these patients, growth failure is an indication for dialysis initiation, and good growth and development during dialysis are the principal indices of dialysis adequacy. There are few published papers describing growth outcomes in infants on CPD and the results form these studies are controversial. Some authors reported positive auxological outcomes [4, 27, 28] , whereas others described stability or worsening of growth indices after 1 year of dialysis treatment [3, 5] . These studies are not easily comparable because of difference in the selected populations. In the cohort studied by Ledermann et al. [4] , mean height SDS at the start of CPD was À1.8 1 1.1, and it increased to À1.1 1 1.2 at 1 year and to À0.8 1 1.4 at 2 years. Eighty per cent of children in this case series (n ¼ 20) were affected by CAKUT but had preserved residual renal function. None of the 20 infants on CPD received rGH therapy, while 18 were given enteral feeding via a nasogastric tube or percutaneous gastrostomy. The authors attributed growth improvement to the optimization of the nutritional measures. Laakkonen et al. [5] reported in 23 infants (13 with congenital nephrotic syndrome of Finnish type) a mean height SDS of À1.9 1 1.2 at the beginning of CPD and À1.6 1 1.8 after 9 months. Previous Italian data showed worsening of weight and height SDS values after 9 months of CPD [3] , and this tendency was confirmed by the present results. However, in our study, a longer follow-up period allowed the demonstration of catch-up growth in half of the treated infants and SDS values at 2 years of follow-up were similar to those at baseline. The initial fall in growth parameters probably reflected the extended period required to achieve adequate CPD regimen and to improve nutritional intakes. Infants require surgical peritoneal catheter placement, prolonged family training with automated cycler equipment, frequent clinical and biochemical controls and attainment of new family dynamics to deal with this type of treatment. Moreover, satisfactory growth outcomes can be reached only if dialysis is associated with an intensive nutritional programme [29] . Some centres routinely use gastrostomy for adequate feeding of infants with ESRD, to ensure sufficient intake of energy, proteins and vitamins. Unfortunately, little information was available from the Italian Registry about the number of infants on enteral feeding. However, the practice of gastrostomy feeding for infants and children with ESRD is not widespread in Italy and many paediatric nephrologists here prefer a nasogastric tube placement for nutrition in the first months of CPD.
In our case series, catch-up growth occurred in 23 of 47 patients (49%). This analysis was performed by comparing the length SDS values at the beginning and after 12 months of dialysis treatment. In infants, linear growth is the most reliable anthropometric measure because it is not biased by the changes in hydration status. As previously described by Laakkonen et al. [5] , infants with positive catch-up growth were not different from those without, with regard to mean values of several biochemical parameters, mean daily diuresis, distribution of comorbidities and proportion of children on rGH treatment. Interestingly, a positive relationship was found after 1 year of CPD between length SDS and both fill volume and treatment duration. Moreover, children with better growth rates suffered from a significantly lower number of peritonitis cases. Both findings are of great practical importance and suggest that PD can be optimized using a maximal dialytic and nutritional approach and by examining all suitable strategies for preventing peritonitis. In infants, dialysis prescription should not be based on the worsening of biochemical parameters but instead should reflect a timely tailoring to body size, residual renal function and metabolic needs.
For the analysis of complications, we found that complications secondary to comorbidities, dialysis status and uraemia were the most incident in our population (1:18.3 episode:CPD-months), followed by peritonitis (1:20.7) and catheter-related infections or mechanical complications (1:21.5). Infants with clinical complications required a median 13 AE 20 days of hospitalization per year and the average hospitalization days per month was significantly greater than that of older children. The hospitalization rate was also longer for neonates because they spent 1.7 inhospital days per CPD-month compared with 0.6 days in children who initiated dialysis at age >12 months. Our findings confirmed the results of Carey et al. [30] and indicated that neonates with ESRD as well as their families incur significant human as well as physical costs. Episodes of over-or dehydration were the most common clinical complications in infants because their nutrition was primarily characterized by liquid diet. In these patients, it is important to increase the caloric content or energy density of the milk; at the same time, it is important to maintain stable fluid intakes and ultrafiltration volumes to avoid excessive weight loss and dangerous episodes of hypotension.
Although the most frequently reported criterion for diagnosing peritonitis was an elevated peritoneal fluid cell count (86% of episodes), we found that 22% had negative cultures, which is similar to NAPRTCS data (25.4%) [13] . The incidence of peritonitis was lower than that reported by other studies in similar patient populations. Although Ledermann et al. [4] reported the highest incidence of 1:7.5, results from three other studies were comparable, ranging from 1:13.9 to 1:15.6 [3, 5, 13] . In agreement with the findings of Boehm et al. [31] , our results confirm oligoanuria as an important risk factor for peritonitis. A decrease in mean daily diuresis creates the need to increase ultrafiltration by means of hyperosmolar glucose solutions, longer nocturnal treatments, a shift from an intermittent to a continuous treatment modality and introduction of day dwells. Such CPD regimens increase the peritoneal membrane exposure to conventional dialysis fluids: this unphysiologic composition adversely affects peritoneal host defence and may thus contribute to the development of PD-related peritonitis [32] . Moreover, infants on CPD with oliguria are frequently dysprotidaemic, with hypogammaglobulinaemia resulting from malnutrition and peritoneal protein losses [33] . A decline in mean daily diuresis has also been associated with a higher risk of inadequate depuration, leading to protein and energy wasting [34] .
Exit-site and tunnel infections were the most frequent causes of catheter-related complications. Catheter replacement was necessary in 15% of these cases and in all complications of mechanical origin. In all three cases of cuff extrusion, the implanted catheter was the Tenckoff type combined with straight tunnel and downward-oriented exit site. Although this may have influenced the risk of cuff extrusion, the number of cases was too small for making firm conclusions. The low incidence of leakage in our population may have been related to the relatively low fill volumes. However, younger age did not appear to be a risk factor for catheter-related complications.
A shift to haemodialysis was required in 21% of infants, and this was due in most cases to refractory or severe peritonitis which precluded further CPD treatment. CPD termination due to peritoneal membrane failure occurred more frequently than in the general population of the Registry [35] . Five of the seven patients who experienced a loss of peritoneal function were affected by non-renal comorbidities (prematurity, hypoxic-ischaemic encephalopathy (two), polymalformative syndrome and visual impairment). Membrane failure occurred after a relatively short treatment period (median 14 months). To explain the early failure, all of these infants started RRT before 3 months of age, they were oligoanuric and required hypertonic PD solutions to obtain adequate ultrafiltration. The incidence of peritonitis in the infants with membrane failure (1:20 episode:CPD-months) was not different from that of the entire group (1:20.7 episode: CPD-months).
Rheault et al. [36] described 23 children who had received CPD prior to 28 days of age. There was significant morbidity during the care of these infants in the first year of life, and the 1-year mortality rate was 48%. Only one of the 17 infants who survived was discharged from the hospital and was fed exclusively per os. All patients who survived longer than 1 year received kidney transplants at a median age of 13.4 months and at median body weight of 9.5 kg. One deceased-donor and 11 living-donor transplants were performed. The infants in our study received kidney transplants after a longer period on dialysis (median 29 months) and at relatively lower body weights (median 11 kg). This indicates a different nutritional and kidney transplant approach, mainly based on preserving oral nutrition and waiting for deceased-donor transplantation.
Overall mortality was 9.5%, which is 4-fold greater than that of older children. Age at the start of chronic dialysis is an important predictor of patient death, and mortality was particularly high in infants starting CPD in the first month of life. The causes of the higher mortality rate in the younger patients have not been clearly defined, but nonrenal comorbidities, already present at CPD initiation, were the main contributors in ours as well as in other infant dialysis series [12, 37, 38] .
The lack of complete nutritional data and of parameters describing dialysis efficiency represent a limit to our study, particularly concerning the analysis between infants having different growth velocities. Incomplete data analysis often characterizes registry-based studies and was caused by unexpected or less careful data entry. However, registry databases allow for the collection of large amounts of information about particular patient categories and they limit bias due to single-centre influences on treatment results.
In conclusion, our data confirm that even though infants represent a high-risk group for complications and death, CPD enables satisfactory treatment outcomes during the waiting period for renal transplantation, even for relatively prolonged periods of time. To optimize dialysis prescription, great care should be aimed at improving both fill volume and treatment duration, at preventing peritonitis and at preserving peritoneal membrane function. Although mortality is still high, it is primarily related to non-renal comorbidities and this must be emphasized when parents are counselled during RRT planning.
